1. Global tuberculosis reports 2013;World Health Organization,2012
2. Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOT;Prihoda;J Med Plant Res,2007
3. Drug-resistant tuberculosis: emerging treatment options;Havlir;JAMA,2008
4. Bedaquiline for the treatment of resistant tuberculosis: promises and pitfalls;Kakkar;Tuberculosis,2014
5. Challenges in the development of drugs for the treatment of tuberculosis;Shehzad;Braz J Infect Dis,2013